Sponsor Pipeline

Novita Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 2/3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07109414 Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant… Platinum-resistant Ovarian Cancer Active, Not Recruiting
Phase 1/2
NCT05023486 NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic… Advanced or Metastatic Solid Tumor Malignancies Active, Not Recruiting
Disease Areas
Ovarian Cancer (1)
Get alerts when Novita Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free